By Professor Susan Jane Connor

Journal articles

Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2017, 'The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus', Internal Medicine Journal, 47, pp. 1263 - 1269, http://dx.doi.org/10.1111/imj.13488

Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; Radford-Smith GL; Moser G, 2017, 'Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method', BMC Medical Genetics, 18, pp. 94, http://dx.doi.org/10.1186/s12881-017-0451-2

Lawrance IC; Baird A; Lightower D; Radford-Smith G; Andrews JM; Connor S, 2017, 'Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis', Clinical Gastroenterology and Hepatology, 15, pp. 1248 - 1255, http://dx.doi.org/10.1016/j.cgh.2017.02.027

Toong CML; Lee MWM; Connor S; Ng W, 2017, 'Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply', Pathology, 49, pp. 334 - 335, http://dx.doi.org/10.1016/j.pathol.2017.01.005

Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ, 2017, 'Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial', The Lancet, 389, pp. 1218 - 1228, http://dx.doi.org/10.1016/S0140-6736(17)30182-4

Doecke JD; Hartnell F; Bampton P; Bell S; Mahy G; Grover Z; Lewindon P; Jones LV; Sewell K; Krishnaprasad K; Prosser R; Marr D; Fischer J; R Thomas G; Tehan JV; Ding NS; Cooke SE; Moss K; Sechi A; De Cruz P; Grafton R; Connor SJ; Lawrance IC; Gearry RB; Andrews JM; Radford-Smith GL, 2017, 'Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study', Alimentary Pharmacology and Therapeutics, 45, pp. 542 - 552, http://dx.doi.org/10.1111/apt.13880

Lawrance IC; Baird A; Lightowler D; Radford-Smith G; Andrews JM; Connor S, 2017, 'OP007 A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis', Journal of Crohn's and Colitis, 11, pp. S4 - S5, http://dx.doi.org/10.1093/ecco-jcc/jjx002.006

Feagan BG; Sandborn WJ; Gasink C; Jacobstein D; Lang Y; Friedman JR; Blank MA; Johanns J; Gao LL; Miao Y; Adedokun OJ; Sands BE; Hanauer SB; Vermeire S; Targan S; Ghosh S; De Villiers WJ; Colombel JF; Tulassay Z; Seidler U; Salzberg BA; Desreumaux P; Lee SD; Loftus EV; Dieleman LA; Katz S; Rutgeerts P; Bampton P; Chung A; Connor S; Debinski H; Leong R; Macrae F; Pavli P; Sorrentino D; van den Bogaerde J; Vogel W; Vogelsang H; Louis E; Mana F; Zaltman C; Aumais G; Bernstein C; Bressler B; Dhalla S; Marshall J; Panaccione R; Ropeleski M; Stehlik J; Volfova M; Brynskov J; Glerup H; Abitbol-Selinger V; Allez M; Beaugerie L; Bourreille A; Cadiot G; Dupas J; Grimaud J; Laharie D; Lerebours E; Moreau J; Baumgart D; Brand S; Ebert M; Ehehalt R; Hasselblatt P; Howaldt S; Klaus J; Krummenerl P; Kucharzik T; Lügering A; Mudter J; Preiss J; Schreiber S; Stallmach A; Stein J; Strauch U; Salamon A; Patchett S; Lahat-Zok A; Rachmilewitz D; Annese V; Bossa F; Guidi L; Kohn A; Rocca R; Ando A; Ashida T; Hanai H; Ishida T; Ito H; Matsumoto T; Motoya S; Nakamura S; Sameshima Y; Suzuki Y; Watanabe K; Yamagami H; Yamamoto T, 2016, 'Ustekinumab as induction and maintenance therapy for Crohn's disease', New England Journal of Medicine, 375, pp. 1946 - 1960, http://dx.doi.org/10.1056/NEJMoa1602773

Stein J; Connor S; Virgin G; Ong DEH; Pereyra L, 2016, 'Anemia and iron deficiency in gastrointestinal and liver conditions', World Journal of Gastroenterology, 22, pp. 7908 - 7925, http://dx.doi.org/10.3748/wjg.v22.i35.7908

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O; Grosen A; Brown SJ; Kjeldsen J; Wildt S; Svenningsen L; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrance IC; Andrews JM; Ellard K; Bell SJ, 2016, 'Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection', Gastroenterology, 151, pp. 110 - 119, http://dx.doi.org/10.1053/j.gastro.2016.04.002

Chen JH; Andrews JM; Kariyawasam V; Moran N; Gounder P; Collins G; Walsh AJ; Connor S; Lee TWT; Koh CE; Chang J; Paramsothy S; Tattersall S; Lemberg DA; Radford-Smith G; Lawrance IC; McLachlan A; Moore GT; Corte C; Katelaris P; Leong RW, 2016, 'Review article: Acute severe ulcerative colitis - Evidence-based consensus statements', Alimentary Pharmacology and Therapeutics, 44, pp. 127 - 144, http://dx.doi.org/10.1111/apt.13670

Connor SJ, 2016, 'Biologic Therapeutic Drug Monitoring in Australia', Journal of Gastroenterology and Hepatology (Australia), 31, pp. 8 - 9, http://dx.doi.org/10.1111/jgh.13346

Elnawsra O; Fok I; Sparrow M; Gibson P; Andrews J; Connor S, 2016, 'Faecal calprotectin: Current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists', Internal Medicine Journal, 46, pp. 590 - 595, http://dx.doi.org/10.1111/imj.13056

Thompson KD; Connor SJ; Walls DM; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup AJ; Sechi A; Girgis A; Rubin DT; Siegel CA, 2016, 'Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications', Inflammatory Bowel Diseases, 22, pp. 940 - 947, http://dx.doi.org/10.1097/MIB.0000000000000740

Andrews JM; Costello SP; Agarwal AK; Bampton P; Beswick L; Connor S; Ghaly S; O'Connor S; Pudipeddi A; Sechi A; Sparrow M; Walsh AJ, 2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, 46, pp. 377 - 379, http://dx.doi.org/10.1111/imj.12989

Sechi A; Sawyer E; Ng WSW; Connor SJ, 2016, 'Mo1089 Proving Cost Effectiveness Through Implementation of a Nurse-Led Inflammatory Bowel Disease (IBD) Patient Advice Line and Virtual Clinic (CHEAP)', Gastroenterology, 150, pp. S631 - S631, http://dx.doi.org/10.1016/s0016-5085(16)32166-7

Bye W; Sparrow M; Connor SJ; Andrews JM; Watson Ng WS; Ellard K; Hume G; Antoniades SA; Walsh A, 2016, 'Su1831 Identifying “At Risk” Inflammatory Bowel Disease Patients Who May Be Targeted With a New Adjuvanted Herpes Zoster Subunit Vaccine', Gastroenterology, 150, pp. S564 - S565, http://dx.doi.org/10.1016/s0016-5085(16)31930-8

Paramsothy S; Walsh AJ; Borody T; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush NO; Kamm MA, 2015, 'Gastroenterologist perceptions of faecal microbiota transplantation', World Journal of Gastroenterology, 21, pp. 10907 - 10914, http://dx.doi.org/10.3748/wjg.v21.i38.10907

Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P; Barr G; Jones B; Connor S; Paven G; Chapman G; Park G; Gearry R; Leong RW, 2015, 'Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia', Clinical Gastroenterology and Hepatology, 13, pp. 1453 - 1463.e1, http://dx.doi.org/10.1016/j.cgh.2015.02.045

Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM, 2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, 45, pp. 659 - 666, http://dx.doi.org/10.1111/imj.12732

Paramsothy S; Borody TJ; Lin E; Finlayson S; Walsh AJ; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush N; Kamm MA, 2015, 'Donor recruitment for fecal microbiota transplantation', Inflammatory Bowel Diseases, 21, pp. 1600 - 1606, http://dx.doi.org/10.1097/MIB.0000000000000405

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Antoniades S; Headon B; Connor S; Lawrance IC; Sparrow M; Walsh AJ; Andrews JM, 2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, 45, pp. 170 - 177, http://dx.doi.org/10.1111/imj.12621

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Kjeldsen J; Wildt S; Svenningsen L; Connell W; Hvas CL; Sparrow M; Walsh A; Connor SJ; Radford-Smith GL; Lawrance IC; Andrews JM; Ellard K; Rosella O; Grosen A; Santamaria JD; Bell S, 2015, '540 Adalimumab and Infliximab Levels in Neonates (ERA Study)', Gastroenterology, 148, pp. S - 108, http://dx.doi.org/10.1016/s0016-5085(15)30372-3

Chen J-H; Corte CJ; Kariyawasam VC; Moran N; Gounder P; Collins GD; Connor SJ; Lee T; Walsh A; Koh CE; Chang J; Paramsothy S; Tattersall SJ; Lemberg DA; McLachlan A; Moore GT; Andrews JM; Leong RW, 2015, 'Su1102 Consensus Statements on the Management of Acute Severe Ulcerative Colitis', Gastroenterology, 148, pp. S - 408, http://dx.doi.org/10.1016/s0016-5085(15)31373-1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Bampton PA; Sechi A; Ng WSW; Connor SJ; Andrews JM, 2015, 'Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study', Gastroenterology, 148, pp. S - 861, http://dx.doi.org/10.1016/s0016-5085(15)32918-8

Ooi S-YJ; Gounder M; Grafton R; Leach P; Bampton PA; Sechi A; Ng WSW; Connor SJ; Andrews JM, 2015, 'Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study', Gastroenterology, 148, pp. S - 861, http://dx.doi.org/10.1016/s0016-5085(15)32919-x

Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM; Annese V; Bampton P; Barnardo M; Bell S; Cole A; Connor SJ; Creed T; Cummings FR; D'Amato M; Daneshmend TK; Fedorak RN; Florin TH; Gaya DR; Greig E; Halfvarson J; Hart A; Irving PM; Jones G; Karban A; Lawrance IC; Lee JC; Lees C; Lev-Tzion R; Lindsay JO; Mansfield J; Mawdsley J; Mazhar Z; Parkes M; Parnell K; Orchard TR; Radford-Smith G; Russell RK; Reffitt D; Satsangi J; Silverberg MS; Sturniolo GC; Tremelling M; Tsianos EV; Van Heel DA; Walsh A; Watermeyer G; Weersma RK; Zeissig S; Rossjohn J; Holden AL; Ahmad T, 2014, 'HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants', Nature Genetics, 46, pp. 1131 - 1134, http://dx.doi.org/10.1038/ng.3093

Julsgaard M; Christensen LA; Fallingborg J; Gearry R; Radford-Smith G; Walsh A; Kjeldsen J; Sparrow MP; Andrews JM; Connor SJ; Lawrence I; Gibson PR; Rosella O; Grosen A; Bell SJ, 2014, 'Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth', JOURNAL OF CROHNS & COLITIS, 8, pp. S34 - S35, http://dx.doi.org/10.1016/S1873-9946(14)60066-0

Julsgaard M; Christensen LA; Lawrence I; Gearry R; Connell W; Grosen A; Svenningsen L; Andrews JM; Bampton P; Walsh A; Moore GT; Radford-Smith G; Brown S; Hvas CL; Kjeldsen J; Connor SJ; Sparrow MP; Fallingborg J; Bell SJ, 2014, 'Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study', JOURNAL OF CROHNS & COLITIS, 8, pp. S222 - S223, http://dx.doi.org/10.1016/S1873-9946(14)60497-9

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Prosser R; Connor S; Lawrance IC; Sparrow M; Bampton P; Walsh A; Andrews J, 2014, 'Short term dose tailoring of anti TNF-alpha therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response', JOURNAL OF CROHNS & COLITIS, 8, pp. S209 - S209, http://dx.doi.org/10.1016/S1873-9946(14)60466-9

Sze KCP; Ng WSW; Connor SJ, 2014, 'Thiopurine metabolite monitoring and allopurinol combination therapy: current utilisation and influence on Australian gastroenterology IBD practice', JOURNAL OF CROHNS & COLITIS, 8, pp. S194 - S194, http://dx.doi.org/10.1016/S1873-9946(14)60432-3

Hussain MI; Hall BM; Depczynski B; Connor SJ, 2014, 'Acute renal failure and metformin-associated lactic acidosis following colonoscopy', Diabetes Research and Clinical Practice, 105, http://dx.doi.org/10.1016/j.diabres.2013.12.055

Ko Y; Karnib M; Samuels D; Alrubaie A; Rahme N; McDonald C; Katelaris P; Barr G; Jones B; Paven G; Chapman G; Park G; Meredith C; Connor S; Gearry R; Leong RWL, 2014, 'Environmental Risk Factors for Inflammatory Bowel Disease: A Case-Control Study in a Middle Eastern Migrant Population', Clinical Gastroenterology and Hepatology, 12, pp. 160 - 161, http://dx.doi.org/10.1016/j.cgh.2013.09.041

Siegel CA; Thompson KD; Walls D; Connor SJ; Stewart SK; Bewtra M; Rubin DT; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Gollins J, 2014, 'Sa1122 Patients With Ulcerative Colitis Are More Concerned About Complications of Their Disease Than Side Effects of Medications', Gastroenterology, 146, pp. S - 205, http://dx.doi.org/10.1016/s0016-5085(14)60726-5

Thompson KD; Connor SJ; Walls D; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Rubin DT; Siegel CA, 2014, 'Sa1123 What Patients Want to Know When Making Decisions About Their Treatment for Ulcerative Colitis: A Mixed Methods Approach Using Affect Trace Technology', Gastroenterology, 146, http://dx.doi.org/10.1016/s0016-5085(14)60727-7

Sze KC; Siriwardana A; Sechi A; Watson Ng WS; Connor SJ, 2014, 'Sa1272 Thiopurine Prescribing and Monitoring Behavior, Including Metabolites Testing and Allopurinol Co-Therapy: An Australian Perspective From 2008 to 2013', Gastroenterology, 146, pp. S - 249, http://dx.doi.org/10.1016/s0016-5085(14)60876-3

Walsh A; Weltman MD; Burger DM; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard A; Grimm M; Travis S; Lawrence IC, 2013, 'Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease', Journal of Crohn's and Colitis, http://dx.doi.org/10.1016/j.crohns.2013.02.019

Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC, 2012, 'Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD', MOLECULAR BIOSYSTEMS, 8, pp. 3125 - 3133, http://dx.doi.org/10.1039/c2mb25194a

Koo JH; You B; Liu K; Athureliya MD; Tang CWY; Redmond D; Connor S; Leong R, 2012, 'Colorectal cancer screening practice is influenced by ethnicity of medical practitioner and patient', Journal of Gastroenterology and Hepatology, 27, pp. 390 - 396

Fok K; Ng WW; Henderson CJ; Connor S, 2012, 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab', Journal of Crohn's and Colitis, 2012, pp. 708 - 712, http://dx.doi.org/10.1016/j.crohns.2012.01.008

Vivekanandarajah S; Guirgis M; Bestic E; Leong RWL; Koo JH; Ng W; Connor S, 2012, 'P331 Role of infliximab as rescue therapy in hospitalised patients with severe, steroid refractory ulcerative colitis. Local experience. Liverpool and Bankstown hospitals, South Western Sydney Local Health District. Australia', Journal of Crohn's and Colitis, 6, pp. S141 - S142, http://dx.doi.org/10.1016/s1873-9946(12)60351-1

Ellard K; Connor S, 2011, 'How to treat', Australian Doctor, pp. 27 - 34

Koo JH; Arasaratnam M; Liu KH; Redmond D; Connor S; Sung JJ; Leong R, 2010, 'Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population', Cancer Epidemiology, 34, pp. 604 - 610, http://dx.doi.org/10.1016/j.canep.2010.05.013

Koo JH; Athureliya MD; Tang CWY; Liu K; Wickramaratne H; Redmond D; Connor SJ; Leong RWL, 2009, 'Colorectal cancer screening practice is influenced by ethnicity of patient and general practitioner', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A224 - A224, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Wong SC; Jalaludin BB; Kneebone AB; Connor SJ; Leong R, 2008, 'Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population', Clinical Gastroenterology and Hepatology, 6, pp. 1016 - 1021

Koo JH; Jalaludin BB; Kneebone AB; Connor SJ; Leong R, 2008, 'Improved survival in young women with colorectal cancer', American Journal of Gastroenterology, 103, pp. 1488 - 1495, http://dx.doi.org/10.1111/j.1572-0241.2007.01779.x

Chin BW; Grimm MC; Connor SJ; Leong RW, 2006, 'Managing inflammatory bowel disease', Medicine Today, 7, pp. 14 - 23

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420

Connor SJ; Paraskevopoulos N; Newman R, 2004, 'CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease (vol 53, pg 1287, 2004)', GUT, 53, pp. 1722 - 1722, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224407200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294

Back to profile page